一个总体策略来比较生物制剂的稳定性坡度,使用从变更后批次的短期数据与从变更前批次的长期数据
1Center for Mathematical Sciences, MSD, Molenstraat 110, 5342 CC, Oss, The Netherlands. jos.weusten@msd.com.
Pharmaceutical research
|December 17, 2025
概括
一种新的贝叶斯方法通过利用所有变更前的数据,有效地比较药物产品稳定性斜率,尽管研究持续时间不同,但确保准确的可比性评估.
科学领域:
- 制药科学 制药科学
- 统计建模 统计建模
- 药物开发 药物开发
背景情况:
- 制药产品的开发涉及持续的改进,需要稳定性评估.
- 制造工艺的变化可能会影响药物的稳定性,需要进行可比性研究.
- 由于研究持续时间和不确定性不同,对更换前和更换后批次之间的稳定性斜率进行直接比较是具有挑战性的.
研究的目的:
- 开发一种可靠的程序来比较药品在变化后的稳定性斜率.
- 为了最大限度地利用所有可用的数据从预更换批次准确的斜率比较.
- 为了解决与不同时间段估计的斜率相比较的固有不确定性.
主要方法:
- 采用贝叶斯分析方法,从完整的变化前数据集中捕获斜率和变化的知识.
- 生成一个后分布来表示变更前数据的信息.
- 变更后的批量斜率是根据从变更前数据中得出的预测分布来评估的.
主要成果:
- 提出的方法已经成功地应用于稳定性可比性研究中的真实数据.
- 该应用证明了贝叶斯方法在制药环境中的实际实用性.
- 结果验证了该方法处理不同研究持续时间的稳定性数据的能力.
结论:
- 开发的贝叶斯方法为评估稳定性斜率的可比性提供了一个合适的框架.
- 该方法提高了产品修改后稳定性评估的可靠性.
- 这种方法有助于确保药品的质量和随着时间的推移保持一致性.
更多相关视频
相关概念视频
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
165
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
165
Bioequivalence Data: Statistical Interpretation
181
Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
181
Drug Product Stability
213
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
213
Bioequivalence studies: Biowaivers
206
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
206
Drug Dissolution: Requirements and Profile Comparison
211
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
211
Drug Products: Biologics, Biosimilars and Interchangeables
217
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
217


